Michael Almaguer
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 6
- Botulinum Toxin and Related Neurological Disorders 1
-
- Genetic Neurodegenerative Diseases 4
-
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 6
- Botulinum Toxin and Related Neurological Disorders 1
-
- Autism Spectrum Disorder Research 1
-
- Glycogen Storage Diseases and Myoclonus 1
-
- Oral and gingival health research 2
-
- Synthetic Organic Chemistry Methods 1
- Co-authors
- Richard K. SimpsonJoseph JankovicWilliam G. OndoChristine HunterWilliam OndoChristopher KenneyAnthony DavidsonKevin Dat Vuong
- Partner nations
- United StatesThailand
In The Last Decade
Michael Almaguer
8 papers receiving 348 citations
Peers
Comparison fields: 5 of 39
- Neurology 332
- Cellular and Molecular Neuroscience 185
- Neurology 36
- Cognitive Neuroscience 32
- Rheumatology 18
Countries citing papers authored by Michael Almaguer
This map shows the geographic impact of Michael Almaguer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Almaguer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Almaguer more than expected).
Fields of papers citing papers by Michael Almaguer
This network shows the impact of papers produced by Michael Almaguer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Almaguer. The network helps show where Michael Almaguer may publish in the future.
Co-authorship network
The 13 scholars most cited alongside Michael Almaguer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 12 | |
| 2 | 2007 | 154 | |
| 3 | 2007 | 14 | |
| 4 | 2007 | 1 | |
| 5 | 2001 | 22 | |
| 6 | 2001 | 96 | |
| 7 | 1999 | 30 | |
| 8 | 1999 | 29 |
About Michael Almaguer
Michael Almaguer is a scholar working on Neurology, Pharmacy and Cellular and Molecular Neuroscience, having authored 8 papers that have together received 358 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (6 papers), Genetic Neurodegenerative Diseases (4 papers), Oral and gingival health research (2 papers), Glycogen Storage Diseases and Myoclonus (1 paper), Botulinum Toxin and Related Neurological Disorders (1 paper), Autism Spectrum Disorder Research (1 paper) and Synthetic Organic Chemistry Methods (1 paper). The work is most often cited by research in Neurology (332 citations), Cellular and Molecular Neuroscience (185 citations) and Neurology (36 citations). Michael Almaguer has collaborated with scholars based in United States and Thailand. Frequent co-authors include Richard K. Simpson, Joseph Jankovic, William G. Ondo, Christine Hunter, William Ondo, Christopher Kenney, Joseph Jankovic, Anthony Davidson, Kevin Dat Vuong and Joseph Jankovic.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.